Saturday, July 25, 2020 10:24:40 PM
Here's my message: Anybody who tries to convince you that what happened that day was only due to the stock being overbought, is trying to bamboozle you. They are not to be trusted. They are not technical analysts, they are frauds. So many words have been wasted to try to justify the crime that was perpetrated; to get everybody to look away; to blame THEMSELVES for holding the stock while they were victims of a financial crime.
There's a word for that: gaslighting. Blaming the abused party. Convincing them it's all in their head. Notice that some folks who deny that anything untoward happened on that fateful day also claim to be stockholders, and were badmouthing the stock repeatedly before the short attack happened. Why would anybody deny an attack happened? We all saw it firsthand, in realtime. They might deny it happened because they have an ulterior motive. If they can rebrand themselves from a basher to a T/A aficionado, they might get people to trust their words. Then, when it's time to try to attack the stock again, they suddenly sound the alarm. GET OUT, the stock is going to collapse!!! Well, the duped say, he warned us all to sell before (he was early, warning everybody from $3 per share, continuing to warn while it rose over 300% from there to $10, but he doesn't mention that). He's warning us again - we should sell!
If you sold that day, you were a victim of a financial crime. If you held that day, you were also a victim of a financial crime. Those who held, you should not to be made to feel like you were unwise. It's not that you didn't read the technicals. You likely believe that Leronlimab will be a success, and you are not willing to be scared by any non-science related attacks.
There will be more attacks, subtle and not. A couple months from now, there might be a whole new shareholder base. The penny flippers might be gone, and long-termers might predominate. If this happens, the shorts will move on to another stock which has a retail shareholder base they perceive as weak. They'll pretend they never heard of CytoDyn. I've seen it over and over again. Andrew Left has been wrong so many times, and he's even changed his mind on a stocks he's been shorting and done a complete 180 degree reversal.
Leronlimab has been proven to work for HIV patients. It met its endpoints in multiple trials culminating in a successful Phase III registration trial. Compelling evidence points to efficacy in HIV mono therapy, Covid-19, and Cancer (etc.). That's what it will all come down to. I'm not going to listen to anybody who says wait for an entry at $4.50. It might drift down, but what if the data comes out and the stock goes to $15 or $20+. Would you make your buy at $20? Or would you say, "Oh, well, shouldn't have waited to buy lower. I guess I won't be owning CYDY. It's too expensive now." This certainly helps the phony "T/A experts" out. Sprinkling the seeds of doubt. "Don't buy yet," they say. Or, "Sell now, it's gonna crash." Softening up the target, again. Don't believe them. I'm sure all of you proficient T/A folks have noticed the phony one's strange and inconsistent T/A posts. They are full of Orwellian doublespeak as pertains to analysis. I can't even read the stuff. Not worth my time, or anybody's time!
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM